Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anne Paakinaho

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Clinical Epidemiology|November 3, 2022
Identification of Drugs Associated with Lower Risk of Parkinson's Disease Using a Systematic Screening Approach in a Nationwide Nested Case-Control StudyMarjaana Koponen, Anne Paakinaho, Julian Lin, et al.
Journal of the American Medical Directors Association|May 23, 2023
Hospitalization and the Risk of Initiation of Antipsychotics in Persons With Parkinson's DiseaseAki Pirttilä, Miia Tiihonen, Anne Paakinaho, et al.
British Journal of Clinical Pharmacology|March 13, 2024
Statin use and the risk of Parkinson's disease in persons with diabetes: A nested case-control studyKim Honkamaa, Anne Paakinaho, Anna-Maija Tolppanen, et al.
Neurology|January 22, 2022
Disease-Modifying Antirheumatic Drugs and Risk of Parkinson Disease: Nested Case-Control Study of People With Rheumatoid ArthritisAnne Paakinaho, Marjaana Koponen, Miia Tiihonen, et al.
Clinical Epidemiology|June 19, 2023
β2-Adrenoceptor Agonists in Asthma or Chronic Obstructive Pulmonary Disease and Risk of Parkinson's Disease: Nested Case-Control StudyAnne Paakinaho, Miia Tiihonen, Heikki Koskela, et al.
International Journal of Clinical Pharmacy|March 8, 2020
Incidence of muscle relaxant use in relation to diagnosis of Parkinson's diseaseAnne Paakinaho, Niina Karttunen, Marjaana Koponen, et al.
Journal of Parkinson'S Disease|May 23, 2025
Incidence of antiepileptic drug use in Parkinson's diseaseSanteri Tuominen, Miia Tiihonen, Anne Paakinaho, et al.
Pharmacoepidemiology and Drug Safety|June 16, 2026
Age, Age-Related Comorbidities and Survival in Palbociclib, Ribociclib and Abemaciclib Users With Advanced Breast Cancer: A Nation-Wide Retrospective Cohort StudyBlair Rajamaki, Olli Tenhunen, Liisa Pylkkänen, et al.
European Journal of Pain (London, England)|June 9, 2025
Incidence of Opioid Use Before and After Parkinson's Disease DiagnosisMajd Al-Sagheer, Niina Karttunen, Anne Paakinaho, et al.
Basic & Clinical Pharmacology & Toxicology|January 29, 2026
Identifying Drugs Associated With Parkinson's Disease Risk Using Machine LearningEeva Pylkkö, Émeline Courtois, Anne Paakinaho, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Clinical Epidemiology|November 3, 2022
Identification of Drugs Associated with Lower Risk of Parkinson's Disease Using a Systematic Screening Approach in a Nationwide Nested Case-Control StudyMarjaana Koponen, Anne Paakinaho, Julian Lin, et al.
Journal of the American Medical Directors Association|May 23, 2023
Hospitalization and the Risk of Initiation of Antipsychotics in Persons With Parkinson's DiseaseAki Pirttilä, Miia Tiihonen, Anne Paakinaho, et al.
British Journal of Clinical Pharmacology|March 13, 2024
Statin use and the risk of Parkinson's disease in persons with diabetes: A nested case-control studyKim Honkamaa, Anne Paakinaho, Anna-Maija Tolppanen, et al.
Neurology|January 22, 2022
Disease-Modifying Antirheumatic Drugs and Risk of Parkinson Disease: Nested Case-Control Study of People With Rheumatoid ArthritisAnne Paakinaho, Marjaana Koponen, Miia Tiihonen, et al.
Clinical Epidemiology|June 19, 2023
β2-Adrenoceptor Agonists in Asthma or Chronic Obstructive Pulmonary Disease and Risk of Parkinson's Disease: Nested Case-Control StudyAnne Paakinaho, Miia Tiihonen, Heikki Koskela, et al.
International Journal of Clinical Pharmacy|March 8, 2020
Incidence of muscle relaxant use in relation to diagnosis of Parkinson's diseaseAnne Paakinaho, Niina Karttunen, Marjaana Koponen, et al.
Journal of Parkinson'S Disease|May 23, 2025
Incidence of antiepileptic drug use in Parkinson's diseaseSanteri Tuominen, Miia Tiihonen, Anne Paakinaho, et al.
Pharmacoepidemiology and Drug Safety|June 16, 2026
Age, Age-Related Comorbidities and Survival in Palbociclib, Ribociclib and Abemaciclib Users With Advanced Breast Cancer: A Nation-Wide Retrospective Cohort StudyBlair Rajamaki, Olli Tenhunen, Liisa Pylkkänen, et al.
European Journal of Pain (London, England)|June 9, 2025
Incidence of Opioid Use Before and After Parkinson's Disease DiagnosisMajd Al-Sagheer, Niina Karttunen, Anne Paakinaho, et al.
Basic & Clinical Pharmacology & Toxicology|January 29, 2026
Identifying Drugs Associated With Parkinson's Disease Risk Using Machine LearningEeva Pylkkö, Émeline Courtois, Anne Paakinaho, et al.
Pageof 2